---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-280186"
form_type: "8-K"
ticker: "BTMD"
cik: "0001819253"
company_name: "biote Corp."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T04:23:25.593128+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Biote Q3 revenue $42M (+18% YoY); expects upper end of 2022 guidance

## Summary
- Revenue $42.0M, up 18% YoY; net loss $(6.3)M, GAAP diluted EPS $(1.74) due to transaction costs.
- Adjusted EBITDA $12.2M (+19% YoY); expects upper end of 2022 revenue $160-$166M and adj. EBITDA $47-$51M.
- Gross margin improved to 68.2% from 65.4% on favorable product mix.
- Operating income $7.8M, down 13% due to $3.1M transaction and legal costs.
- Cash from operations $6.4M in Q3; sales force expansion on track.

## SEC filing metadata
- accession: 0001193125-22-280186
- form_type: 8-K
- ticker: BTMD
- cik: 0001819253
- company_name: biote Corp.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819253/000119312522280186/0001193125-22-280186-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819253/000119312522280186/d402691d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-280186
- JSON: https://secwatch.observer/filing/0001193125-22-280186.json
- Plain text: https://secwatch.observer/filing/0001193125-22-280186.txt

## Key facts
- Earnings Releases
  biote Corp. reported the third quarter ended September 30, 2022 results: revenue $42.0 million, net income $(6.3) million, EPS $(1.74). Guidance reaffirmed.
  - Period: the third quarter ended September 30, 2022
  - Revenue: $42.0 million
  - Net income: $(6.3) million
  - EPS: $(1.74)
  - Guidance: reaffirmed
  - Result: reported results
  source text: set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Biote Reports Third Quarter Financial Results Strong Third Quarter Revenue of $42 million Driven by Growth in Procedures 2022 Revenue and Adjusted EBITDA Expected at Upper End of Guidance IRVING, TX – November 8, 2022 - Biote (NASDAQ: BTMD), a leading provider of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819253/000119312522280186/0001193125-22-280186-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.